[96a5a0]: / output / allTrials / identified / NCT06844357_identified.json

Download this file

297 lines (297 with data), 11.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
{
"info": {
"nct_id": "NCT06844357",
"official_title": "A Multi-center, Randomized, Controlled, Open-label Phase II/III Clinical Trial to Investigate Whether Transarterial Tirapazamine Injection Followed by Transarterial Embolization (TATE) is Superior to Traditional Transarterial Chemoembolization (TACE) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC)",
"inclusion_criteria": "* Patients diagnosed with primary hepatocellular carcinoma according to AASLD criteria.\n* No evidence of extrahepatic metastasis, regional lymph node involvement, or vascular tumor thrombus.\n* Patients must be eligible for TAE or TACE treatment.\n* ECOG ≤ 1.\n* Child-Pugh score ≤ 7.\n* Adequate bone marrow, liver, and kidney function is required.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* History of liver transplantation.\n* Previous radioemblization or radiotherapy for liver tumors.\n* severe cardiovascular or renal diseases, active systemic infections.\n* Clinically significant hypoxia (oxygen saturation < 92% without oxygen supplementation)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients diagnosed with primary hepatocellular carcinoma according to AASLD criteria.",
"criterions": [
{
"exact_snippets": "diagnosed with primary hepatocellular carcinoma",
"criterion": "primary hepatocellular carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "according to AASLD criteria",
"criterion": "AASLD criteria",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "* No evidence of extrahepatic metastasis, regional lymph node involvement, or vascular tumor thrombus.",
"criterions": [
{
"exact_snippets": "No evidence of extrahepatic metastasis",
"criterion": "extrahepatic metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No evidence of ... regional lymph node involvement",
"criterion": "regional lymph node involvement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No evidence of ... vascular tumor thrombus",
"criterion": "vascular tumor thrombus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must be eligible for TAE or TACE treatment.",
"criterions": [
{
"exact_snippets": "eligible for TAE or TACE treatment",
"criterion": "TAE or TACE treatment eligibility",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
}
]
},
{
"line": "* ECOG ≤ 1.",
"criterions": [
{
"exact_snippets": "ECOG ≤ 1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "performance status",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Child-Pugh score ≤ 7.",
"criterions": [
{
"exact_snippets": "Child-Pugh score ≤ 7",
"criterion": "Child-Pugh score",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 7,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Adequate bone marrow, liver, and kidney function is required.",
"criterions": [
{
"exact_snippets": "Adequate bone marrow ... function is required.",
"criterion": "bone marrow function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... liver ... function is required.",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... kidney function is required.",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* History of liver transplantation.",
"criterions": [
{
"exact_snippets": "History of liver transplantation",
"criterion": "liver transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous radioemblization or radiotherapy for liver tumors.",
"criterions": [
{
"exact_snippets": "Previous radioemblization ... for liver tumors.",
"criterion": "radioemblization for liver tumors",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "Previous ... radiotherapy for liver tumors.",
"criterion": "radiotherapy for liver tumors",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* severe cardiovascular or renal diseases, active systemic infections.",
"criterions": [
{
"exact_snippets": "severe cardiovascular ... diseases",
"criterion": "cardiovascular diseases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
},
{
"exact_snippets": "severe ... renal diseases",
"criterion": "renal diseases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
},
{
"exact_snippets": "active systemic infections",
"criterion": "systemic infections",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
}
]
},
{
"line": "* Clinically significant hypoxia (oxygen saturation < 92% without oxygen supplementation)",
"criterions": [
{
"exact_snippets": "Clinically significant hypoxia (oxygen saturation < 92% without oxygen supplementation)",
"criterion": "oxygen saturation",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
},
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 92,
"unit": "%"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}